Anastrozole Tablet
Product Images NDC 23155-857

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Anastrozole (NDC 23155-857). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avet Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7b4ba0c5 0287 B7a7 E053 2991aa0a575e

FDA Label Image

Avet Logo (Avet)

FDA Label Image

30's (Bottle Label 30)

30's (Bottle Label  30)
Avet Pharma® ELTR tablets contain Anastrozole, a USP medication used in the treatment of certain types of breast cancer. The text also includes a product code and the quantity (30 Tablets).*
FDA Label Image

500's (Bottle Label 500)

FDA Label Image

90's (Bottle Label 90)

FDA Label Image

Chemical Structure For Anastrozole (Image 01)

FDA Label Image

Figure 1 (Image 02)

Figure 1 (Image 02)
This is a presentation of data from a clinical trial comparing two drugs, anastrozole and tamoxifen, for the treatment of a disease. The text shows the proportion of patients who were alive and disease-free over a period of 90 months. The number of patients at risk for each drug is also provided at different time points.*
FDA Label Image

Figure 2 (Image 03)

Figure 2 (Image 03)
This seems to be a chart that shows the comparison between the effects of anastrozole and tamoxifen on disease-free survival of patients undergoing some kind of randomized treatment, for a period of up to 90 months. The number of patients at risk is also displayed.*
FDA Label Image

Figure 3 (Image 04)

FDA Label Image

Figure 4 (Image 05)

Figure 4 (Image 05)
This is a plot of Kaplan-Meier curves comparing the treatment outcomes of Anastrozole and Tamoxifen on a group of patients over 120 months. The y-axis shows the survival time, and the x-axis shows the months from treatment initiation. The plot shows the number of patients still under treatment at the given months. However, the text is not entirely clear, and some characters are missing, and therefore some information is missing, and the plot's context cannot be fully confirmed.*
FDA Label Image

Figure 5 (Image 06)

FDA Label Image

Figure 6 (Image 07)

Figure 6 (Image 07)
Not available. The text seems to be a sequence of numbers and some symbols but does not convey any coherent meaning or information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.